Agilon Health Inc (AGL)

NYSE · Healthcare · Medical Care Facilities · USA

Agilon Health Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Care Facilities industry.

Agilon Health partners with primary care physician groups to manage Medicare patient care under value-based payment models. The company operates through risk-bearing entities that contract with health plans on a capitation basis and coordinate care with anchor physician groups. Its platform supports physicians transitioning to a Total Care Model while sharing savings from improved quality and cost management.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Agilon Health Inc stock.

Our verdict on AGL

Undervalued: intrinsic value $455.54 per share, market price $115.20, margin of safety 74.7% (as of 2026-11-17).

A 1.2x revenue multiple, discounted for its losses, values the shares at $455.54; the price of $115.20 is 75% below that value.

ETFs with the most weight in AGL

17 more funds hold it; the full list is part of the paid plan.

More on AGL

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than AGL in Medical Care Facilities

Is AGL undervalued or overvalued?

AGL is undervalued (as of the 2026-11-17 close). A 1.2x revenue multiple, discounted for its losses, values the shares at $455.54; the price of $115.20 is 75% below that value.

What is the intrinsic value of AGL?

$455.54 per share (as of the 2026-11-17 close), against a market price of $115.20. That is a margin of safety of 74.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.